vs

Side-by-side financial comparison of A. O. Smith (AOS) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $945.6M, roughly 1.3× A. O. Smith). Dexcom runs the higher net margin — 21.2% vs 12.5%, a 8.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -2.0%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -3.9%).

A. O. Smith Corporation is an American manufacturer of both residential and commercial water heaters and boilers, and the largest manufacturer and marketer of water heaters in North America. It also supplies water treatment and purification products in the Asian market. The company has 27 locations worldwide, including five manufacturing facilities in North America, as well as plants in Bengaluru in India, Nanjing in China and Veldhoven in The Netherlands.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

AOS vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.3× larger
DXCM
$1.3B
$945.6M
AOS
Growing faster (revenue YoY)
DXCM
DXCM
+23.6% gap
DXCM
21.6%
-2.0%
AOS
Higher net margin
DXCM
DXCM
8.7% more per $
DXCM
21.2%
12.5%
AOS
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-3.9%
AOS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AOS
AOS
DXCM
DXCM
Revenue
$945.6M
$1.3B
Net Profit
$118.0M
$267.3M
Gross Margin
38.7%
62.9%
Operating Margin
25.6%
Net Margin
12.5%
21.2%
Revenue YoY
-2.0%
21.6%
Net Profit YoY
-14.0%
153.6%
EPS (diluted)
$0.85
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AOS
AOS
DXCM
DXCM
Q1 26
$945.6M
$1.3B
Q4 25
$912.5M
$1.3B
Q3 25
$942.5M
$1.2B
Q2 25
$1.0B
$1.2B
Q1 25
$963.9M
$1.0B
Q4 24
$912.4M
$1.1B
Q3 24
$902.6M
$994.2M
Q2 24
$1.0B
$1.0B
Net Profit
AOS
AOS
DXCM
DXCM
Q1 26
$118.0M
$267.3M
Q4 25
$125.4M
$267.3M
Q3 25
$132.0M
$283.8M
Q2 25
$152.2M
$179.8M
Q1 25
$136.6M
$105.4M
Q4 24
$109.7M
$151.7M
Q3 24
$120.1M
$134.6M
Q2 24
$156.2M
$143.5M
Gross Margin
AOS
AOS
DXCM
DXCM
Q1 26
38.7%
62.9%
Q4 25
38.4%
62.9%
Q3 25
38.7%
60.5%
Q2 25
39.3%
59.5%
Q1 25
38.9%
56.9%
Q4 24
37.1%
58.9%
Q3 24
37.4%
59.7%
Q2 24
38.7%
62.4%
Operating Margin
AOS
AOS
DXCM
DXCM
Q1 26
25.6%
Q4 25
17.9%
25.6%
Q3 25
18.6%
20.1%
Q2 25
20.4%
18.4%
Q1 25
19.1%
12.9%
Q4 24
10.1%
17.0%
Q3 24
19.5%
15.3%
Q2 24
21.9%
15.7%
Net Margin
AOS
AOS
DXCM
DXCM
Q1 26
12.5%
21.2%
Q4 25
13.7%
21.2%
Q3 25
14.0%
23.5%
Q2 25
15.0%
15.5%
Q1 25
14.2%
10.2%
Q4 24
12.0%
13.6%
Q3 24
13.3%
13.5%
Q2 24
15.2%
14.3%
EPS (diluted)
AOS
AOS
DXCM
DXCM
Q1 26
$0.85
$0.67
Q4 25
$0.89
$0.67
Q3 25
$0.94
$0.70
Q2 25
$1.07
$0.45
Q1 25
$0.95
$0.27
Q4 24
$0.75
$0.37
Q3 24
$0.82
$0.34
Q2 24
$1.06
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AOS
AOS
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$185.2M
$917.7M
Total DebtLower is stronger
$574.2M
Stockholders' EquityBook value
$1.9B
$2.7B
Total Assets
$3.7B
$6.3B
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AOS
AOS
DXCM
DXCM
Q1 26
$185.2M
$917.7M
Q4 25
$193.2M
$917.7M
Q3 25
$172.8M
$1.8B
Q2 25
$177.9M
$1.2B
Q1 25
$200.2M
$904.9M
Q4 24
$276.1M
$606.1M
Q3 24
$255.6M
$621.2M
Q2 24
$233.3M
$939.2M
Total Debt
AOS
AOS
DXCM
DXCM
Q1 26
$574.2M
Q4 25
$155.0M
Q3 25
Q2 25
Q1 25
Q4 24
$193.2M
Q3 24
Q2 24
Stockholders' Equity
AOS
AOS
DXCM
DXCM
Q1 26
$1.9B
$2.7B
Q4 25
$1.9B
$2.7B
Q3 25
$1.8B
$2.7B
Q2 25
$1.8B
$2.6B
Q1 25
$1.9B
$2.3B
Q4 24
$1.9B
$2.1B
Q3 24
$1.9B
$2.0B
Q2 24
$1.9B
$2.4B
Total Assets
AOS
AOS
DXCM
DXCM
Q1 26
$3.7B
$6.3B
Q4 25
$3.1B
$6.3B
Q3 25
$3.2B
$7.5B
Q2 25
$3.2B
$7.3B
Q1 25
$3.3B
$6.8B
Q4 24
$3.2B
$6.5B
Q3 24
$3.2B
$6.4B
Q2 24
$3.2B
$6.8B
Debt / Equity
AOS
AOS
DXCM
DXCM
Q1 26
0.31×
Q4 25
0.08×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AOS
AOS
DXCM
DXCM
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$118.9M
FCF MarginFCF / Revenue
12.6%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$647.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AOS
AOS
DXCM
DXCM
Q1 26
Q4 25
$183.1M
$294.0M
Q3 25
$255.4M
$659.9M
Q2 25
$139.6M
$303.0M
Q1 25
$38.7M
$183.8M
Q4 24
$221.9M
$301.4M
Q3 24
$195.9M
$199.5M
Q2 24
$57.4M
$279.4M
Free Cash Flow
AOS
AOS
DXCM
DXCM
Q1 26
$118.9M
Q4 25
$165.5M
$192.1M
Q3 25
$240.6M
$579.4M
Q2 25
$122.5M
$208.9M
Q1 25
$17.4M
$96.8M
Q4 24
$191.3M
$176.8M
Q3 24
$163.4M
$88.3M
Q2 24
$34.5M
$213.3M
FCF Margin
AOS
AOS
DXCM
DXCM
Q1 26
12.6%
Q4 25
18.1%
15.3%
Q3 25
25.5%
47.9%
Q2 25
12.1%
18.1%
Q1 25
1.8%
9.3%
Q4 24
21.0%
15.9%
Q3 24
18.1%
8.9%
Q2 24
3.4%
21.2%
Capex Intensity
AOS
AOS
DXCM
DXCM
Q1 26
1.1%
Q4 25
1.9%
8.1%
Q3 25
1.6%
6.7%
Q2 25
1.7%
8.1%
Q1 25
2.2%
8.4%
Q4 24
3.4%
11.2%
Q3 24
3.6%
11.2%
Q2 24
2.2%
6.6%
Cash Conversion
AOS
AOS
DXCM
DXCM
Q1 26
Q4 25
1.46×
1.10×
Q3 25
1.93×
2.33×
Q2 25
0.92×
1.69×
Q1 25
0.28×
1.74×
Q4 24
2.02×
1.99×
Q3 24
1.63×
1.48×
Q2 24
0.37×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons